Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor–associated myocarditis
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Jiajun Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chongqing University, Chongqing 400030, China. Hauptthemen laut MEDLINE: Myocarditis, Immune Checkpoint Inhibitors, CD4-Positive T-Lymphocytes, Disease Models, Animal. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Aims
The widespread use of immune checkpoint inhibitors (ICIs) has demonstrated significant survival benefits for cancer patients and also carries the risk of immune-related adverse events. ICI-associated myocarditis is a rare and serious adverse event with a high mortality rate. Here, we explored the mechanism underlying ICI-associated myocarditis. Methods and results Using the peripheral blood of patients with ICI therapy and of ICI-treated mice with transplanted tumours, we dissect the immune cell subsets and inflammatory factors associated with myocarditis. Compared to the control group, patients with myocarditis after ICI therapy showed an increase in NK cells and myeloid cells in the peripheral blood, while T cells significantly decreased. Among T cells, there was an imbalance of CD4/CD8 ratio in the peripheral blood of myocarditis patients, with a significant decrease in central memory CD4+ T (CD4+ TCM) cells. RNA sequencing revealed that CD4+ TCM cells in myocarditis patients were immunosuppressive cell subsets, which highly express the immunosuppressive factor IL-4I1. To elucidate the potential mechanism of the decrease in CD4+ TCM cells, protein array was performed and revealed that several inflammatory factors gradually increased with the severity of myocarditis in the myocarditis group, such as IL-1B/CXCL13/CXCL9, while the myocardial protective factor IL-15 decreased. Correlation analysis indicated a positive correlation between IL-15 and CD4+ TCM cells, with high expression of IL-15 receptor IL15RA. Furthermore, in vivo studies using an anti-PDL1 antibody in a mouse tumour model indicated a reduction in CD4+ TCM cells and an increase in effector memory-expressing CD45RA CD8+ T (TEMRA) cells, alongside evidence of cardiac fibrosis. Conversely, combining anti-PDL1 antibody treatment with IL-15 led to a resurgence of CD4+ TCM cells, a reduction in CD8+ TEMRA cells, and a mitigated risk of cardiac fibrosis.
Conclusion
Our data highlight CD4+ TCM cells’ crucial role in cardiac protection during ICI therapy. IL-15, IL-4I1, and CD4+ TCM cells can serve as therapeutic targets to reduce ICI-associated myocarditis in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Chongqing University, Chongqing 400030, China.
- Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, No. 181, Hanyulu, Shapingba, Chongqing 400030, China.
- Department of Cardio-Oncology, Chongqing University Cancer Hospital, No. 181, Hanyulu, Shapingba, Chongqing 400030, China.
- Department of Medical Oncology, Chongqing University Cancer Hospital, No. 181, Hanyulu, Shapingba, Chongqing 400030, China.
ORCID-Profile: Juanjuan Shan
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Natural Science Foundation of Chongqing
Zitieren
APA
Yu, J., Long, B., Li, Z., Tian, X., Li, D., Long, J., Wang, Y., Chen, Y., Zhang, F., Liu, H., Qian, C., & Shan, J. (2024). Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor–associated myocarditis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae133
Vancouver
Yu J, Long B, Li Z, Tian X, Li D, Long J, et al. Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor–associated myocarditis. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae133
BibTeX
@article{Yu2024,
author = {Yu, Jiajun and Long, Bo and Li, Ziyong and Tian, Xiaolong and Li, Dairong and Long, Jianling and Wang, Yujue and Chen, Yue and Zhang, Fang and Liu, Haixia and Qian, Cheng and Shan, Juanjuan},
title = {Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor–associated myocarditis},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae133}
}
EUVIMED